Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retinal Consultants of San Diego is a premier clinical practice and research institution specializing in the diagnosis and treatment of vitreoretinal diseases. The organization operates the Retina Research Institute of San Diego, which serves as a high-volume site for Phase 1 through Phase 3 clinical trials evaluating novel therapies for conditions such as wet age-related macular degeneration and geographic atrophy. The practice provides advanced surgical and medical interventions, including intravitreal injections, laser therapy, and complex vitrectomy. As a member of the Retina Consultants of America network, they collaborate extensively with major pharmaceutical and biotechnology companies to advance ophthalmic care. Their team includes nationally recognized experts who contribute to the development of standard-of-care treatments for retinal pathologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retinal Consultants of San Diego.